Scientific Proof &
Peer-Reviewed Studies
Backed by independent, FDA-compliant laboratory testing and real-world results.
70%+ Reduction in Healthcare-Associated Infections
A rigorous, peer-reviewed study demonstrates that ActivePure Technology achieved a massive >70% reduction in Healthcare-Associated Infections (HAIs) within hospital settings.
Unlike passive filters that wait for pathogens to reach them, ActivePure aggressively neutralizes airborne and surface contaminants at the source, preventing cross-contamination in the most critical environments.
- Significant reductions in fungal, bacterial, and viral surface loads.
- Validated by the Journal of Hospital Infection.
- Proactive defense that works 24/7 in occupied spaces.
Rapid ≥99.9% Pathogen Inactivation
ActivePure has been tested against some of the most dangerous pathogens known to humanity, yielding consistent ≥99.9% reductions in FDA-compliant independent laboratories.
Key efficacy results include:
Reduces over 99.99% of airborne SARS-CoV-2 virus within 1 to 3 minutes.
Proven to rapidly inactivate airborne viruses, safeguarding vulnerable populations like children and the elderly.
Uncompromised Safety: Proven by PLOS ONE
When it comes to deploying air and surface purification in occupied spaces, safety is non-negotiable. A rigorous 90-day study published in the peer-reviewed journal PLOS ONE confirmed the absolute safety of ActivePure Technology.
90-Day Exposure
Mice were exposed to ActivePure molecules continuously for 90 days with careful monitoring of all physiological parameters.
Zero Adverse Effects
The study found absolutely no adverse effects on lung tissue, cardiovascular health, or overall well-being.
Safe for Occupied Spaces
This definitive peer-reviewed evidence proves that ActivePure can run safely 24/7 around humans and pets.